Tufts CSDD Study Identifies Opportunities for Drug Sponsors

Conducted in collaboration with The Avoca Group, based on an analysis of data provided by 76 varied sized pharmaceutical companies engaged in global drug development, a newly completed study from the Tufts Center for the Study of Drug Development says large sponsors have significantly longer and more variable process completion-to-contract stages than other companies.

For more from the study, click here.